Integrin alpha V (ITGAV) expression in esophageal adenocarcinoma is associated with shortened overall-survival

Valid biomarkers for a better prognostic prediction of the clinical course in esophageal adenocarcinoma (EAC) are still not implemented. Integrin alpha V (ITGAV), a transmembrane glycoprotein responsible for cell-to-matrix binding has been found to enhance tumor progression in several tumor entities...

Descripción completa

Detalles Bibliográficos
Autores principales: Loeser, Heike, Scholz, Matthias, Fuchs, Hans, Essakly, Ahlem, Damanakis, Alexander Iannos, Zander, Thomas, Büttner, Reinhard, Schröder, Wolfgang, Bruns, Christiane, Quaas, Alexander, Gebauer, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591891/
https://www.ncbi.nlm.nih.gov/pubmed/33110104
http://dx.doi.org/10.1038/s41598-020-75085-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591891/
https://www.ncbi.nlm.nih.gov/pubmed/33110104
http://dx.doi.org/10.1038/s41598-020-75085-7

Ejemplares similares